Bank Of America Corp Dexcom Inc Put Options Transaction History

Bank Of America Corp

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$64.0 - $116.06 $14.1 Million - $25.6 Million	-220,200 Reduced 96.41%	8,200 $549,000
Q2 2024 Aug 14, 2024	BUY	$110.31 - $140.45 $10.7 Million - $13.7 Million	97,200 Added 74.09%	228,400 $25.9 Million
Q1 2024 May 15, 2024	SELL	$114.22 - $140.1 $11 Million - $13.4 Million	-95,900 Reduced 42.23%	131,200 $18.2 Million
Q4 2023 Feb 14, 2024	SELL	$75.49 - $124.16 $11.7 Million - $19.3 Million	-155,300 Reduced 40.61%	227,100 $28.2 Million
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $37.4 Million - $43.5 Million	332,400 Added 664.8%	382,400 $49.1 Million
Q1 2023 May 12, 2023	BUY	$104.0 - $122.92 $5.2 Million - $6.15 Million	50,000 New	50,000 $5.81 Million
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $572,625 - $706,350	-7,500 Reduced 24.43%	23,200 $1.87 Million
Q2 2022 Aug 12, 2022	BUY	$67.99 - $132.89 $1.37 Million - $2.68 Million	20,200 Added 192.38%	30,700 $2.29 Million
Q4 2021 Feb 08, 2022	BUY	$129.87 - $162.82 $467,532 - $586,152	3,600 Added 52.17%	10,500 $5.64 Million
Q3 2021 Nov 15, 2021	BUY	$106.71 - $143.18 $736,299 - $987,942	6,900 New	6,900 $3.77 Million

1,015

349M

5.66M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $28.8B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.